The millennium bugs--the need for and development of new antibacterials.

[1]  J. Ambler,et al.  Activity of Gemifloxacin against Penicillin- and Ciprofloxacin-Resistant Streptococcus pneumoniae Displaying Topoisomerase- and Efflux-Mediated Resistance Mechanisms , 1999, Antimicrobial Agents and Chemotherapy.

[2]  K. Pedersen.  Some growth promoters in animals do confer antimicrobial resistance in humans , 1999, BMJ.

[3]  D. Low,et al.  Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds. , 1999, Diagnostic microbiology and infectious disease.

[4]  R. Moellering.  A Novel Antimicrobial Agent Joins the Battle against Resistant Bacteria , 1999, Annals of Internal Medicine.

[5]  Claude Carbón,et al.  Regulating the use of antibiotics in the community , 1998, BMJ.

[6]  Ronald N. Jones,et al.  Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) , 1998, Antimicrobial Agents and Chemotherapy.

[7]  M. Jacobs,et al.  Susceptibilities of Penicillin- and Erythromycin-Susceptible and -Resistant Pneumococci to HMR 3647 (RU 66647), a New Ketolide, Compared with Susceptibilities to 17 Other Agents , 1998, Antimicrobial Agents and Chemotherapy.

[8]  J. McCormick.  Epidemiology of emerging/re-emerging antimicrobial-resistant bacterial pathogens. , 1998, Current opinion in microbiology.

[9]  Y. Fukuchi,et al.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin , 1997, The Lancet.

[10]  P Huovinen,et al.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. , 1997, The New England journal of medicine.

[11]  G Poste,et al.  The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics , 1997, Antimicrobial agents and chemotherapy.

[12]  R. Moellering,et al.  Antimicrobial-drug resistance. , 1996, The New England journal of medicine.

[13]  P. Davey,et al.  Growth in the use of antibiotics in the community in England and Scotland in 1980-93 , 1996, BMJ.

[14]  Ken-Ichi Fujita,et al.  Decline of erythromycin resistance of group A streptococci in Japan. , 1994, The Pediatric infectious disease journal.

[15]  W. Craig.  Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  J. Coast,et al.  An economic perspective on policy to reduce antimicrobial resistance. , 1998, Social science & medicine.

[17]  W. Craig.  The future--can we learn from the past? , 1997, Diagnostic microbiology and infectious disease.

[18]  R. Bax,et al.  Antibiotic resistance: a view from the pharmaceutical industry. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  N. Høiby.  Epidemiologic aspects on antibiotic resistance. , 1995, Microbial drug resistance.